Last reviewed · How we verify
ACESULFAME POTASSIUM
ACESULFAME POTASSIUM is a drug. It is currently FDA-approved.
At a glance
| Generic name | ACESULFAME POTASSIUM |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- SweetSpot - The Effect of Non-nutritive Sweeteners on Health (NA)
- Saccharin and Acesulfame Potassium Consumption and Glucose Homeostasis in Older Adults With Prediabetes (NA)
- Effect of Non-nutritive Sweeteners of High Sugar Sweetened Beverages on Metabolic Health and Gut Microbiome (NA)
- Intergenerational Transmission of Low-calorie Sweeteners Via Breast Milk (NA)
- The Effects of a Novel Mitochondrial Substrate Supplement on Exercise Performance and Cognitive Function (NA)
- Treatment of Radiation and Cisplatin Induced Toxicities with Tempol (PHASE2)
- Effects of Oral Xylitol on Subsequent Energy Intake (NA)
- Fluid Loading Countermeasures (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ACESULFAME POTASSIUM CI brief — competitive landscape report
- ACESULFAME POTASSIUM updates RSS · CI watch RSS
Frequently asked questions about ACESULFAME POTASSIUM
What is ACESULFAME POTASSIUM?
ACESULFAME POTASSIUM is a Small molecule drug.
What development phase is ACESULFAME POTASSIUM in?
ACESULFAME POTASSIUM is FDA-approved (marketed).
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing